Business Wire - MEDA: Astepro patent granted

Posted by admin / Under Azelastine

December 1, 2011 --

GÖTEBORG, Sweden -- Regulatory News:

The United States Patent and Trademark Office (USPTO) today issued a...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Business Wire - MEDA: Dymista Filed in Europe

Posted by admin / Under Azelastine

October 28, 2011 --

GÖTEBORG, Sweden -- Regulatory News:

The marketing authorization application for Dymista (a novel...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Nordic Business Report - -Meda files for approval of Dymista in Europe

Posted by admin / Under Azelastine

October 1, 2011 --

NORDIC BUSINESS REPORT-October 31, 2011--Meda files for approval of Dymista in Europe(C)2011 M2 COMMUNICATIONS http://www.m2.com

31...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Nordic Business Report - -Meda releases positive Phase III data for Dymista

Posted by admin / Under Azelastine

June 15, 2011 --

NORDIC BUSINESS REPORT-June 15, 2011--Meda releases positive Phase III data for Dymista(C)2011 M2 COMMUNICATIONS http://www.m2.com

15...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Business Wire - Meda: Dymista filed with the FDA

Posted by admin / Under Azelastine

April 4, 2011 -- HASH(0x64a9ae0)

GÖTEBORG, Sweden -- Regulatory News

A New Drug Application for a novel formulation...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Nordic Business Report - -Meda applies for US approval of rhinitis spray

Posted by admin / Under Azelastine

April 4, 2011 --

NORDIC BUSINESS REPORT-April 4, 2011--Meda applies for US approval of rhinitis spray(C)2011 M2 COMMUNICATIONS http://www.m2.com

4...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Business Wire - Meda: Positive Study Results Presented for Dymista

Posted by admin / Under Azelastine

March 22, 2011 -- HASH(0x13ec3f60)

GÖTEBORG, Sweden -- Regulatory News:

Meda (STO:MEDAA) announced today positive...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Nordic Business Report - -Swedish Meda announces positive phase III data for Dymista

Posted by admin / Under Azelastine

March 22, 2011 --

NORDIC BUSINESS REPORT-March 22, 2011--Swedish Meda announces positive phase III data for Dymista(C)2011 M2 COMMUNICATIONS...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Business Wire - Research and Markets: Azelastine - Key Patent, SPC, and Data Exclusivity Expiry (7 Country Coverage)

Posted by admin / Under Azelastine

March 3, 2011 -- HASH(0xba66b60)

DUBLIN -- Research and Markets (

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading

Journal of Drugs in Dermatology - Part III: cutaneous hypersensitivity during selective serotonin reuptake inhibitor therapy resulting in acquired cutis laxa

Posted by admin / Under Azelastine

February 1, 2011 --

CASE REPORT

A 44-year-old female presented with a two-year history of erythematous axillary and inframammary lesions, progressing to...

Published on Wednesday 8th of February 2012 10:07:30 AM

continue reading